AstraZeneca Falls 7.3% On Bristol Myers Squibb Talks
AstraZeneca shares drop on potential combination talks
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
AstraZeneca shares drop on potential combination talks
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.